AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Actemra 162mg Injection

Prescription Icon
Prescription Required

Marketer

Roche Products India Pvt Ltd

Salt Composition

Tocilizumab (162mg)

Overview Actemra 162mg Injection

Tocilizumab 162mg injection treats diverse inflammatory disorders affecting joints (rheumatoid, psoriatic, and ankylosing spondylitis), skin (psoriasis), and intestines (ulcerative colitis, Crohn's disease). Its mechanism involves TNF-alpha inhibition, reducing inflammation. Administered by a medical professional, this injection requires regular, consistent daily use for optimal results. Continue treatment as prescribed, completing the full course even with symptom improvement. Common adverse effects include headache, elevated blood pressure, upper respiratory infections, elevated liver enzymes, and nasopharyngitis. Persistent or bothersome side effects warrant immediate consultation with your physician, who can advise on management strategies. Increased infection susceptibility is possible. Report any infection symptoms—fever, cough, rash, diarrhea, or flu-like illness—promptly. Prior to treatment, disclose any heart, kidney, or liver conditions, as well as all other medications. Regular blood tests may monitor blood cell counts during treatment. Pregnant or breastfeeding individuals should seek medical counsel before commencing treatment.

Primary Ingredients of Actemra 162mg Injection

No text provided. Please provide the text you wish me to rephrase.

Uses of Actemra 162mg Injection

Management strategies for ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease.

Major Benefits of Actemra 162mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Actemra 162mg Injection:

  • Headache
  • High blood pressure
  • Upper respiratory tract infection
  • Injection site reactions (pain, swelling, redness)

How to use Actemra 162mg Injection:

Administering this medication will be performed by your healthcare provider. Self-medication is strictly prohibited.

How Actemra 162mg Injection works:

Tocilizumab 162mg injection inhibits specific inflammatory mediators, thereby reducing the associated swelling, redness, and inflammation characteristic of some arthritic conditions.

SAFETY ADVICE

AlcoholAlcoholSAFE

Actemra 162mg Injection does not interact negatively with alcohol consumption.

PregnancyPregnancyCONSULT YOUR DOCTOR

Tocilizumab 162mg injection may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the benefits against potential hazards prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can likely use Actemra 162mg Injection safely. Available human data indicates minimal infant risk associated with the medication.

DrivingDrivingUNSAFE

Tocilizumab 162mg injection can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Tocilizumab 162mg injection requires careful administration in individuals with renal impairment. Dosage modification of tocilizumab 162mg injection may be necessary. Physician consultation is advised. Data regarding the use of tocilizumab 162mg injection in patients exhibiting moderate to severe kidney disease is limited. Dosage alteration is unnecessary for patients with mild kidney dysfunction.

LiverLiverCAUTION

Tocilizumab 162mg injection requires careful administration in individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. The 162mg tocilizumab injection is contraindicated in those with active liver disease.

What if you forget to take Actemra 162mg Injection :

Should you forget a scheduled Actemra 162mg Injection, seek medical advice immediately.

Facts to Know About Actemra 162mg Injection

LabelValue
Chemical Type Monoclonal antibody
Developing Good Habits No.
Treatment Category Cancer Therapeutics
Actions Biologic Disease-Modifying Antirheumatic Drugs (DMARDs)

FAQs on Actemra 162mg Injection

Actemra 162mg Injection treats moderate-to-severe Covid-19 patients with persistent, worsening hypoxia despite 24-48 hours of corticosteroid and supportive care.
Actemra 162mg Injection isn't suitable for all COVID-19 patients due to potential adverse effects. Its use carries the risk of persistent serious infection and prolonged viral shedding, necessitating careful risk-benefit assessment before administration.
Actemra 162mg Injection may cause serious side effects, including anaphylaxis during infusion, elevated liver enzymes (transaminitis), and low white blood cell counts (leukopenia and neutropenia), increasing infection risk. Further potential side effects are serious bacterial and viral infections, and tuberculosis reactivation.
Actemra 162mg Injection is contraindicated in patients with abnormal liver enzyme levels (transaminitis), low platelet counts (<50,000), tuberculosis, or any active bacterial or viral infection. Its use is also contraindicated during pregnancy and breastfeeding due to the risk of serious complications.
If your condition doesn't improve after Actemra 162mg Injection, your doctor will determine the next steps. While Actemra reduces lung inflammation, it doesn't repair pre-existing damage; lung recovery takes time. Continued shortness of breath warrants further investigation for potential complications like pulmonary intravascular coagulopathy, cardiac dysfunction, or other infections, which would need separate treatment.
Actemra 162mg Injection
95,320